Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac

Author:

Liu Min1,Liu Mingzhe1,Yang Feng2,Liu Yanhua1,Wang Shoulong2,Chen Yazhen3,Li Ji2,Wang Xianliang2,Orlandini Lucia Clara2

Affiliation:

1. College of Nuclear Technology and Automation Engineering, Chengdu University of Technology

2. Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University and Electronic Science and Technology of China

3. Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University

Abstract

Abstract

Background: To investigate the impact of using contrast-enhanced computed tomography (CHCT) in the dosimetry of stereotactic body radiation therapy (SBRT) for liver metastases treated with MR-Linac. Methods: A retrospective study was conducted on 21 liver cancer patients treated with SBRT (50Gy in 5 fractions) using a 1.5 Tesla Unity MR-Linac. The clinical treatment plans optimised on plain computed tomography (pCT) were used as reference. The electronic density (ED) of regions of interest (ROIs) including the liver, duodenum, esophagus, spinal cord, heart, ribs, and lungs, from pCT and CHCT, was analysed. The average ED of each ROI from CHCT was used to generate synthetic CT (sCT) images by assigning the average ED value from the CHCT to the pCT. Clinical plans were recalculated on sCT images. Dosimetric comparisons between the original treatment plan (TPpCT) and the sCT plan (TPsCT) were performed using dose-volume histogram (DVH) parameters, and gamma analysis. Results: Significant ED differences (p<0.05) were observed in the liver, great vessels, heart, lungs, and spinal cord between CHCT and pCT, with the lungs showing the largest differences (average deviation of 11.73% and 12.15 % for the left and right lung, respectively). The target volume covered by the prescribed dose (VDpre), and the dose received by 2% and 98% of the volume (D2%, and D98%,respectively) showed statistical differences (p < 0.05), while the gradient index (GI) and the conformity index (CI) did not. Average deviations in target volume dosimetric parameters were below 1.02%, with a maximum deviation of 5.57% for Dmin. For the organs at risk (OARs), significant differences (p < 0.05) were observed for D_0.35cc and D1.2cc of the spinal cord, D_10cc for the stomach, D0.5cc for the heart, and D30% for the liver-GTV, with mean deviations lower than 1.83% for all the above OARs. Gamma analysis using 2%-2mm criteria yielded a median value of 95.64 % (range 82.22% to 99.65%) for the target volume and 99.40 % (range 58% to 100%) for the OARs. Conclusion: The findings indicate that using CHCT in the SBRT workflow for liver metastases may result in minor target volume overdosage. This potential discrepancy suggests that CHCT should not be adopted as a standard practice in clinical settings.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3